MARKET

PRLD

PRLD

Prelude Therapeutics Inc
NASDAQ
0.7680
-0.0317
-3.96%
After Hours: 0.7900 +0.022 +2.86% 17:04 03/31 EDT
OPEN
0.7668
PREV CLOSE
0.7997
HIGH
0.8700
LOW
0.7500
VOLUME
1.03M
TURNOVER
0
52 WEEK HIGH
6.80
52 WEEK LOW
0.6300
MARKET CAP
42.36M
P/E (TTM)
-0.4578
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PRLD last week (0324-0328)?
Weekly Report · 12h ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 3d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 3d ago
Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 3d ago
Prelude Therapeutics CEO Makes Bold Stock Purchase!
TipRanks · 3d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 4d ago
Prelude Therapeutics CEO buys $467K in common stock
TipRanks · 4d ago
Weekly Report: what happened at PRLD last week (0317-0321)?
Weekly Report · 03/24 09:23
More
About PRLD
More
Prelude Therapeutics Incorporated is a clinical-stage fully integrated oncology company built on a foundation of drug discovery to deliver novel precision cancer medicines to underserved patients. It has developed a diverse pipeline consisting of multiple distinct programs: kinases, targeted protein degraders, and precision antibody drug conjugates. Its product candidates include PRT3789, PRT2527 and PRT7732. PRT3789 is a highly selective degrader of SMARCA2 protein, which, along with SMARCA4, controls gene regulation through chromatin remodeling. Its CDK9 program is an essential regulator of cancer-promoting transcriptional programs, including those driven by MCL1, MYC and MYB. PRT2527 is designed to be a potent and selective CDK9 inhibitor that has the potential to avoid off-target toxicities observed with other less selective CDK9 inhibitor. PRT7732 is a highly selective and orally bioavailable SMARCA2 degrader.
Recently
Symbol
Price
%Change

Webull offers Prelude Therapeutics Inc stock information, including NASDAQ: PRLD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRLD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRLD stock methods without spending real money on the virtual paper trading platform.